Continuum Advisory’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.42K Buy
+77
New +$3.25K ﹤0.01% 1682
2025
Q2
Sell
-66
Closed -$1.41K 1218
2025
Q1
$1.41K Buy
66
+14
+27% +$313 ﹤0.01% 1444
2024
Q4
$1.09K Hold
52
﹤0.01% 1597
2024
Q3
$1.29K Buy
+52
New +$1K ﹤0.01% 1575

Other funds holding PAHC

Continuum Advisory's PAHC Position: Q2 2026 in Review

Continuum Advisory opened a new position in Phibro Animal Health (PAHC) in Q2 2026: 77 shares worth $2.42K. The stake represents ﹤0.01% of the portfolio and ranks #1682 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in PAHC as recently as Q1 2025.

Continuum Advisory first reported a position in PAHC in Q3 2024 and has held it in 4 quarters since. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Continuum Advisory held 77 shares of Phibro Animal Health worth $2.42K as of Q2 2026.
  • Phibro Animal Health was a new Continuum Advisory position in Q2 2026.
  • Phibro Animal Health made up ﹤0.01% of Continuum Advisory's portfolio in Q2 2026, its #1682 holding.
  • Continuum Advisory first reported a position in Phibro Animal Health in Q3 2024 and has held it in 4 quarters since.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.